| |

Risks: Drugs / Vaccines / Trials / Treatments

Risks: Drugs / Vaccines / Trials / Treatment Evidence of antidepressant harm Oct 14, 2005: Andrew Finkelstein Letter to Dr. Russell Katz, Director, Neuropharmacological Drug Products, FDA about FDA’s Failure to Warn about Neurontin-Suicides Aug 29: FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks…

Congress Bars EPA from accepting human pesticide data

Congress Bars EPA from accepting human pesticide data Thu, 28 Jul 2005 Thank you Senator Barbara Boxer and Representative Hilda Solis for leading the charge to stop the Environmental Protection Agency in its tracks. The EPA was formulating rules that would have oveturened the Nuremberg Code prohibition against using poisonous…

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D Fri, 9 Dec 2005 Recent reports describing a determined effort to pathologize US infants and toddlers who are being declared to suffer from “severe mental disorders”–the latest, most aggressively marketed diagnosis for children is Bipolar disorder,…

Vaccines the culprit – Not-So-Crackpot Autism Theory – NYT

Vaccines the culprit – Not-So-Crackpot Autism Theory – NYT Sun, 10 Nov 2002 A report in Sunday’s NY Times Magazine (excerpt below) reveals as much about the culture of arrogance exhibited by those who formulate public health policy, as it does about the link (long-denied) between a vaccine preservative containing…

SSRI Defects: Infants Suffer Drug Withdrawal / Adults risk GI bleeding

SSRI Defects: Infants Suffer Drug Withdrawal / Adults risk GI bleeding Wed, 18 May 2005 The Associated Press reports that new research confirms that: “Babies born to women taking antidepressants in the last three months of pregnancy were three times more likely to develop drug-related symptoms than those born to…

| | |

AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising

AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:  Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00….

APA Claims Credit for Censoring News Report about Mental Screening

APA Claims Credit for Censoring News Report about Mental Screening Sun, 16 Oct 2005 The American Psychiatric Association acknowledges its role in suppressing a major news story about the President’s New Freedom Commission Report recommendation. That recommendation is the center of a heated debate among advocates for personal privacy, parental…

August 20, 2001

August 20, 2001 A landmark decision by Maryland’s highest court, the Court of Appeals of Maryland, is a victory for the human rights of children.  The decision affirms the responsibility of parents, the government, researchers and institutional review boards (IRB) to protect children from non-therapeutic experiments that may put their health…

| | |

AHRP Testimony: Protections for Foster Children Enrolled in Clinical Trials Submitted to Cong.Ways & Means Hearing

 THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://ahrp.org 142 West End Ave. Suite 28P New York, NY 10023 Testimony by The Alliance for Human Research Protection Committee on Ways and Means Hearing on Protections for Foster Children Enrolled in Clinical Trials May 18, 2005 On March 10, 2004, The ALLIANCE…

AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research

AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research Wed, 30 Nov 2005 Help us stop a proposed government policy that would lead to the proliferation of unthinkable human pesticide experiments such as the infamous CHEERS experiment. CHEERS was designed to expose toddlers to pesticides so that EPA investigators…

Janssen Admits Hiding Risperdal Risks / TMAP & Illinois Mental Health Screening

Janssen Pharma Admits Hiding Risperdal Drug Risks / TMAP & Illinois Mental Health Screening Plan Sat, 24 Jul 2004 The Miami Herald reports (below) that in a letter to doctors, Janssen Pharmacia, manufacturer of the highly promoted drug, Risperdal (risperidone), admitted “misleading doctors and other healthcare providers about the safety…